Saseen discusses the current dyslipidemia treatment landscape, highlighting current challenges and potential paths forward.
National Lipid Association(NLA)
Latest Content
The practice of genetic testing has been useful in clinically addressing found cases of familial hypercholesterolemia, among other conditions, but no clinical practice guidelines currently exist for testing patients with suspected hereditary dyslipidemia.
Advertisement
Advertisement
Trending on HCPLive
1
FDA Approves Olezarsen (Tryngolza) for Severe Hypertriglyceridemia
2
Delgocitinib Approval Fills a Long-Standing Gap in Chronic Hand Eczema Treatment
3
The Medical Sisterhood: The Strength Nobody Talks About, with Saakshi Khattri, MD
4
Q&A: Cardiometabolic Care Cascade Failure Points, with Rishi Wadhera, MD, MPP, MPhil
5